Chairman of the Board Mr. Wu joined the Board of Directors of SHL as a Director in May 2017. He is the Vice President and CTO of the Beijing Hospmall Technology Co., Ltd. which is a leading internet medical company in China since 2014. Prior to that, he served as Senior Manager and Chief Architect in Digital Film Research Institute of Dadi Culture Communication Group, and Project Manager in Research and Development Center of Toshiba (China).
Mr. Wu has many years of experience in system architecture design and software development, as well as in technical team management and project management. Mr. Wu holds a Bachelor degree from National University of Defense Technology, a Master degree from Tsinghua University, and a Doctor degree from Beijing Normal University, China.
Mr. Su joined the Board of Directors of SHL as a Director in May 2017. Mr. Su is the Vice Chairman of the Board of Directors of Shenzhen Yanghe Biomedicine Industry Investment Co., Ltd. in China since 2013. Since 2002, Mr. Su served in various executive positions in Zhuhai Hokai Medical Instruments Co., Ltd., a leading public listed Chinese medical device company, as its Board member, Vice President and Board Secretary from 2007 to November 2013. From 1995 to 2002, Mr. Su was the Manager of Business Development Department, Credit Department and Legal Affairs Department of Zhuhai Branch, the Bank of East Asia, Ltd., a bank based in Hong Kong. Mr. Su holds an MBA from Murdoch University, Australia. Nationality: Chinese.
Dr. Amir Lerman
Dr. Lerman joined the Board of Directors of SHL as a non-executive Director in 2016. Dr. Lerman is the Director of the Cardiovascular Research Center at the Mayo Clinic in Rochester (USA) since 2013. He is also the Program Director for vascular and valve, Center for Regenerative Medicine at the Mayo Clinic, since 2012, and Vice-Chair, Cardiovascular Department and chair for Cardiovascular research at the Mayo Clinic, since 2013. In addition, Dr. Lerman serves as the Director of the Mayo-Israeli start up company initiative as well as a faculty member at the Mirage Institute: US-Israel innovation bridge business leadership program, since 2009, in addition to various other positions held at the Mayo Clinic. Dr. Lerman also holds an appointment as Professor of Medicine at the Mayo Medical School since 2001. Dr. Lerman graduated from the Technion school of Medicine in Haifa Israel in 1985 and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic in 1994. Dr. Lerman published more than 500 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research. Nationality: American/ Israeli.
Ms. Shenlu Xu joined the Board of Directors of SHL as a Director in May 2017. Ms. Xu is currently pursuing a Juris Doctor degree at Harvard Law School where she focuses her studies on corporate transactions and corporate governance. Previously, Ms Xu obtained a Bachelor of Business Administration (Accounting and Finance) from University of Hong Kong where she was awarded several scholarships and graduated with first class honors.
She has years of experience in investing in the stock market and has interned with various financial institutions and law firms, such as Simpson Thacher & Bartlett LLP, Taikang Asset Management, Himalaya TMT Fund and Hadef & Partners. Ms. Xu is the daughter of Mr. Xu Xiang, who is the Managing Director of Himalaya Asset Management Limited.
Nationality: Hong Kong SAR, China.
Mr. He joined the Board of Directors of SHL as a Director in May 2017. He is the Co-founder and CEO of the Beijing Hospmall Technology Co., Ltd. From 2008 to 2014, He is the Vice General Manager and Board Director in Mengdong Energy Holding Company. Prior to that, he served as Vice Present and Director of Asset Management in Zhongke Merchants Investment Group. Mr. He holds a BA degree from China Youth University for Political Sciences, a Master degree from Chinese Academy of Sciences, and an EMBA from China Europe International Business School.
Yehoshua (Shuky) Abramovich
Mr. Abramovich joined the Board of Directors of SHL as a non-executive Director in 2017. Mr. Abramovich has held key positions in the Israeli capital market for over 25 years. He serves as the chairman of the board of Somoto limited ,chairman of Atrade , Member of the board of directors and chairman of the investment committee of I.D.I Insurance company and as a director in few other high-tech companies. Mr. Abramovich was the CEO of Clal Finance during several years, one of Israel’s largest financial institution who provided a broad array of financial services ranging from portfolio management to brokerage and underwriting services. Clal Finance owned and managed mutual funds, an in-house hedge fund, and offered individually tailored structured products to clients.. Prior to that, he served in various positions in Clal group, including Deputy CEO of Clal Insurance Enterprises Holdings. He served on the board of directors of the Tel-Aviv Stock Exchange until Sept 2009,and he is a member of the board of trustees of the Academic Track of the College of Management (COM). He has a B.A. in Economics & business management and a MBA from Tel Aviv University. Nationality: Israeli.